Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Turnstone Biologics
Biotech
Turnstone narrows cell therapy focus to 'high unmet need' tumors
Turnstone is narrowing the focus of phase 1 trials of its lead tumor-infiltrating lymphocyte, with cutaneous melanoma and breast cancer off the menu.
James Waldron
Aug 15, 2024 7:46am
Turnstone turns fortunes around with $80M IPO haul
Jul 21, 2023 9:25am
Booted by Big Pharma, Turnstone files IPO to fund cell therapies
Jun 13, 2023 9:40am
Takeda cuts ties to cancer drug landed in $120M Turnstone deal
Jul 28, 2022 7:00am
ASCO: Takeda Oncology ready to stoke partnerships
Jun 9, 2022 7:30am
2seventy bio plucks Turnstone exec Bernstein to be new CMO
Feb 14, 2022 10:34am
